Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases. (Q47830583)

6 February 2018

title

Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases. (English)

1 reference

6 February 2018

1 reference

7

Marsden CD

1 reference

6 February 2018

8

Schapira AH

1 reference

6 February 2018

author name string

Gu M

1

1 reference

6 February 2018

Owen AD

2

1 reference

6 February 2018

Toffa SE

3

1 reference

6 February 2018

Cooper JM

4

1 reference

6 February 2018

Dexter DT

5

1 reference

6 February 2018

Jenner P

6

1 reference

6 February 2018

publication date

1 June 1998

1 reference

6 February 2018

Journal of the Neurological Sciences

published in

1 reference

6 February 2018

volume

158

1 reference

6 February 2018

issue

1

1 reference

6 February 2018

page(s)

24-29

1 reference

6 February 2018

Evidence of an oxidative challenge in the Alzheimer's brain

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900095-1

Mitochondrial function in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900095-1

L-dopa does not affect electron transfer chain enzymes and respiration of rat muscle mitochondria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900095-1

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900095-1

Decreased ferritin levels in brain in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900095-1

Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900095-1

Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900095-1

Mitochondrial defect in Huntington's disease caudate nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900095-1

Iron induced oxidative stress and mitochondrial dysfunction: relevance to Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900095-1

Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900095-1

Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900095-1

A clinicopathologic study of 100 cases of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900095-1

Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900095-1

New insights into the cause of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900095-1

Brain Cytochrome Oxidase in Alzheimer's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900095-1

Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900095-1

Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900095-1

Complex I, iron, and ferritin in Parkinson's disease substantia nigra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900095-1

Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900095-1

Effect of dopamine, dimethoxyphenylethylamine, papaverine, and related compounds on mitochondrial respiration and complex I activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900095-1

Electron transport chain defects in Alzheimer's disease brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900095-1

Parkinson's disease: a disorder due to nigral glutathione deficiency?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900095-1

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900095-1

Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900095-1

Analyses of energy metabolism and mitochondrial genome in post-mortem brain from patients with Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900095-1

Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900095-1

A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900095-1

Mitochondrial complex I deficiency in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900095-1

Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900095-1

Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900095-1

Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900095-1

High-performance liquid chromatographic analysis of glutathione and its thiol and disulfide degradation products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2898%2900095-1

10.1016/S0022-510X(98)00095-1

7 January 2021

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018